Telithromycin

泰利霉素

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameTelithromycin
Drug Alias Name替利霉素TelithromycinumTelitromicina泰利霉索Levviax +[9] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsCommunity Acquired PneumoniaOtitis MediaAsthma +[12] 
Global Approved IndicationsCommunity Acquired PneumoniaSinusitisPneumonia +[8] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2001/07/09
Country/TerritoryUnited StatesFranceEU +[4] 
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiSanofi-Aventis U.S. LlcAventis Pharma Sa
Active IndicationsN/A
Inactive IndicationsCommunity Acquired PneumoniaOtitis MediaAsthma +[12] 

Other Information

ATC CodeJ01FA15
Related LinksWikipediaDrugBankKEGG